Fulcrum Therapeutics Inc. (FULC) Misses Q1 EPS by 2c

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.

You May Also Be Interested In

• Mosaic (MOS), Others Lower Following Trump Post on Potash from Belarus
• Strategy (MSTR) call put ratio 2.3 calls to 1 put as share price up 8.3%
• Trump: US working on massive deal with respect to the purchase of potash from Belarus